These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 37547355)

  • 1. Secondary Sclerosing Cholangitis After SARS-CoV2: ICU Ketamine Use or Virus-Specific Biliary Tropism and Injury in the Context of Biliary Ischemia in Critically Ill Patients?
    Bartoli A; Cursaro C; Seferi H; Andreone P
    Hepat Med; 2023; 15():93-112. PubMed ID: 37547355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatobiliary long-term consequences of COVID-19: dramatically increased rate of secondary sclerosing cholangitis in critically ill COVID-19 patients.
    Leonhardt S; Jürgensen C; Frohme J; Grajecki D; Adler A; Sigal M; Leonhardt J; Voll JM; Kruse JM; Körner R; Eckardt KU; Janssen HJ; Gebhardt V; Schmittner MD; ; Frey C; Müller-Ide H; Bauer M; Thibeault C; Kurth F; Sander LE; Müller T; Tacke F
    Hepatol Int; 2023 Dec; 17(6):1610-1625. PubMed ID: 37119516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secondary sclerosing cholangitis in critically ill patients: current perspectives.
    Gudnason HO; Björnsson ES
    Clin Exp Gastroenterol; 2017; 10():105-111. PubMed ID: 28694703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biliary Cast Syndrome and Secondary Sclerosing Cholangitis in Critically Ill Patient after Long-Term Treatment in the Intensive Care Unit.
    Alkurdi A; Herrmann J; Bikmukhametov D; Tschöpe R
    Case Rep Gastroenterol; 2024; 18(1):260-265. PubMed ID: 38737441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ischemic-like cholangiopathy with secondary sclerosing cholangitis in critically ill patients.
    Gelbmann CM; Rümmele P; Wimmer M; Hofstädter F; Göhlmann B; Endlicher E; Kullmann F; Langgartner J; Schölmerich J
    Am J Gastroenterol; 2007 Jun; 102(6):1221-9. PubMed ID: 17531010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secondary sclerosing cholangitis in critically ill patients has a poor outcome but lower tumour incidence than primary sclerosing cholangitis.
    Kirstein MM; Book T; Manns MP; von Hahn T; Voigtländer T
    United European Gastroenterol J; 2020 Jul; 8(6):716-724. PubMed ID: 32366182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-Covid-19 Cholangiopathy-A New Indication for Liver Transplantation: A Case Report.
    Durazo FA; Nicholas AA; Mahaffey JJ; Sova S; Evans JJ; Trivella JP; Loy V; Kim J; Zimmerman MA; Hong JC
    Transplant Proc; 2021 May; 53(4):1132-1137. PubMed ID: 33846012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19-associated secondary sclerosing cholangitis with liver transplantation.
    Fischer AK; Stippel D; Canbay A; Nierhoff D; Thomas M; Best J; Büttner R; Drebber U
    Virchows Arch; 2024 Mar; ():. PubMed ID: 38526652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secondary sclerosing cholangitis in a young COVID-19 patient resulting in death: A case report.
    Steiner J; Kaufmann-Bühler AK; Fuchsjäger M; Schemmer P; Talakić E
    World J Gastrointest Surg; 2022 Dec; 14(12):1411-1417. PubMed ID: 36632122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secondary Sclerosing Cholangitis Following Coronavirus Disease 2019 (COVID-19): A Multicenter Retrospective Study.
    Hunyady P; Streller L; Rüther DF; Groba SR; Bettinger D; Fitting D; Hamesch K; Marquardt JU; Mücke VT; Finkelmeier F; Sekandarzad A; Wengenmayer T; Bounidane A; Weiss F; Peiffer KH; Schlevogt B; Zeuzem S; Waidmann O; Hollenbach M; Kirstein MM; Kluwe J; Kütting F; Mücke MM
    Clin Infect Dis; 2023 Feb; 76(3):e179-e187. PubMed ID: 35809032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secondary sclerosing cholangitis.
    Ruemmele P; Hofstaedter F; Gelbmann CM
    Nat Rev Gastroenterol Hepatol; 2009 May; 6(5):287-95. PubMed ID: 19404269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meta-analysis and systematic review of liver transplantation as an ultimate treatment option for secondary sclerosing cholangitis.
    Gadour E; Hassan Z
    Prz Gastroenterol; 2022; 17(1):1-8. PubMed ID: 35371357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe acute respiratory syndrome coronavirus-2-associated cholangiopathies.
    Bartoli A; Cursaro C; Andreone P
    Curr Opin Gastroenterol; 2022 Mar; 38(2):89-97. PubMed ID: 35098930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early detection of COVID-19 cholangiopathy using cholangioscopy-a case report of two critically ill patients.
    Kroepfl V; Treml B; Freund MC; Profanter C
    Eur Surg; 2022; 54(6):326-330. PubMed ID: 36189108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secondary sclerosing cholangitis as cause of persistent jaundice in patients with severe COVID-19.
    Bütikofer S; Lenggenhager D; Wendel Garcia PD; Maggio EM; Haberecker M; Reiner CS; Brüllmann G; Buehler PK; Gubler C; Müllhaupt B; Jüngst C; Morell B
    Liver Int; 2021 Oct; 41(10):2404-2417. PubMed ID: 34018314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secondary Sclerosing Cholangitis in Critically Ill Patients: Clinical Presentation, Cholangiographic Features, Natural History, and Outcome: A Series of 16 Cases.
    Leonhardt S; Veltzke-Schlieker W; Adler A; Schott E; Eurich D; Faber W; Neuhaus P; Seehofer D
    Medicine (Baltimore); 2015 Dec; 94(49):e2188. PubMed ID: 26656347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on Sclerosing Cholangitis in Critically Ill Patients.
    Kirchner GI; Rümmele P
    Viszeralmedizin; 2015 Jun; 31(3):178-84. PubMed ID: 26468312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secondary sclerosing cholangitis after COVID-19 pneumonia: a report of two cases and review of the literature.
    Bauer U; Pavlova D; Abbassi R; Lahmer T; Geisler F; Schmid RM; Ehmer U
    Clin J Gastroenterol; 2022 Dec; 15(6):1124-1129. PubMed ID: 35953614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics of Bilirubin and Ammonia Elimination during Hemadsorption Therapy in Secondary Sclerosing Cholangitis Following ECMO Therapy and Severe COVID-19.
    Tampe D; Korsten P; Bremer SCB; Winkler MS; Tampe B
    Biomedicines; 2021 Dec; 9(12):. PubMed ID: 34944657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of Secondary Sclerosing Cholangitis in Hospitalized Long COVID-19 Patients: A Retrospective Single Center Study.
    Werner CR; Fusco S; Kienzle K; Döbele S; Artzner K; Malek NP; Wichmann D; Göpel S
    Diagnostics (Basel); 2024 Mar; 14(7):. PubMed ID: 38611659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.